Skip to main content

Hims & Hers Health, Inc.

HIMS
Exchange
NYSE
Industry
Services-Offices & Clinics of Doctors of Medicine
SEC CIK
0001773751

In the last 90 days, Hims & Hers Health, Inc. insiders filed 0 open-market purchases and 14 sales; 511 institutions reported holding it in 13F filings for Q2 2026, worth $5.39B in total; no superinvestor holds it.

Key figures

Market capNo recent share count in SEC filings
–
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $6.00M in total
14
13F holdersQ2 2026, +79 vs. previous quarter
511
13F valueReported value at the end of Q2 2026
$5.39B
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$2.35B
+59.0% year over year
Net income, FY2025
$128.4M
+1.8% year over year
Free cash flow, FY2025
$57.4M
−71.0% year over year
Revenue, Q3 FY2026
$890.4M
+48.6% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
51.7M
Shares sold short
Change
−1.82M
−3.4% vs. previous
Days to cover
5.84
At average daily volume

Superinvestors holding HIMS, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding HIMS at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Hims & Hers Health, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 29, 2026 (view filing)4:11 PM ETOct 281 dayBoughton SoleilChief Legal OfficerSSaleClass A Common Stock−3.46K$27.60−$95.6K−1.2%293.9K after10b5-1
Oct 15, 2026 (view filing)4:44 PM ETOct 141 dayBoughton SoleilChief Legal OfficerSSaleClass A Common Stock−3.46K$29.06−$100.6K−1.2%297.3K after10b5-1
Oct 2, 2026 (view filing)4:32 PM ETOct 11 dayOkupe OluyemiChief Financial OfficerSSaleClass A Common Stock−2.00K$29.70−$59.4K−0.8%234.5K after10b5-1
Oct 2, 2026 (view filing)4:31 PM ETSep 302 daysBoughton SoleilChief Legal OfficerSSaleClass A Common Stock−3.46K$29.17−$101.0K−1.1%300.8K after10b5-1
Sep 23, 2026 (view filing)4:17 PM ETSep 221 dayOkupe OluyemiChief Financial OfficerSSaleClass A Common Stock−29.3K$29.95−$876.8K−11.0%236.5K after10b5-1
Sep 18, 2026 (view filing)4:17 PM ETSep 171 dayOkupe OluyemiChief Financial OfficerSSaleClass A Common Stock−12.3K$28.82−$354.9K−4.7%251.8K after10b5-1
Sep 17, 2026 (view filing)4:17 PM ETSep 161 dayBoughton SoleilChief Legal OfficerSSaleClass A Common Stock−6.24K$27.86−$173.7K−2.0%304.3K after10b5-1
Sep 17, 2026 (view filing)4:17 PM ETSep 152 daysChi MichaelChief Operating OfficerSSaleClass A Common Stock−14.0K$28.39−$398.2K−3.0%456.7K after10b5-1
Sep 17, 2026 (view filing)4:17 PM ETSep 152 daysElshenawy MohamedCTOSSaleClass A Common Stock−7.95K$28.39−$225.8K−4.1%185.6K after10b5-1
Sep 3, 2026 (view filing)4:31 PM ETSep 21 dayBoughton SoleilChief Legal OfficerSSaleClass A Common Stock−3.46K$28.33−$98.0K−1.1%310.5K after10b5-1

Top 10 13F holders, Q2 2026

See all 511 holders

The largest institutional positions in Hims & Hers Health, Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding HIMS in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.28,703,514$995.2M0.01%+2,366,356+9.0%Added
Vanguard Portfolio Management LLC10,559,314$366.1M0.02%+375,501+3.7%Added
Vanguard Capital Management LLC9,541,384$330.8M0.01%+201,673+2.2%Added
State Street Corp8,145,699$282.4M0.01%+685,676+9.2%Added
Morgan Stanley7,152,498$248.0M0.01%−1,736,590−19.5%Reduced
Divisadero Street Capital Management, LP6,009,505$208.3M4.86%+5,539,672+1,179.1%Added
Geode Capital Management, LLC5,681,832$197.0M0.01%+483,053+9.3%Added
Goldman Sachs Group Inc5,173,865$179.4M0.02%+2,719,170+110.8%Added
JPMorgan Chase & Co4,766,781$159.5M0.01%−474,035−9.0%Reduced
FMR LLC4,323,292$149.9M0.01%+4,230,022+4,535.2%Added

Holders of 5% or more of HIMS

See all 3 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Hims & Hers Health, Inc..

Largest holders of HIMS from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A11.90%26.5M shares+1.10 ppfrom 10.80%Oct 22, 20244 filingsJul 28, 2026SEC
Dudum Andrew13D/A9.40%22.6M shares−0.90 ppfrom 10.30%Feb 1, 20215 filingsAug 31, 2026SEC
Susquehanna Securities, LLC13G6.50%14.5M sharesNewMay 15, 20261 filingMay 15, 2026SEC

1 member of Congress reported 1 trade in Hims & Hers Health, Inc. since 2020. Newest filings:

  1. Lisa C. McClain

    House · MI · Sep 12, 2025

    Buy$1K-$15K